HomeNewsTrendsHealthCOVID-19 relief hits cash-strapped NGOs hard, finds survey
Trending Topics

COVID-19 relief hits cash-strapped NGOs hard, finds survey

Voluntary organisations say diversion of CSR funds towards management of COVID-19 pandemic and relief efforts and greater compliance have added to their difficulties.

June 06, 2022 / 20:25 IST
Story continues below Advertisement
A man with breathing problem is wheeled inside a COVID-19 hospital for treatment in Ahmedabad. (Representative image: Reuters)
A man with breathing problem is wheeled inside a COVID-19 hospital for treatment in Ahmedabad. (Representative image: Reuters)

Non-governmental organisations (NGOs) are facing severe financial difficulties as most funds and donations have been diverted towards management of the COVID-19 pandemic and relief efforts, said a new study.

The survey conducted by The/Nudge Foundation, a Bengaluru-based NGO, found out that with funds diverted to COVID-19 healthcare and immediate relief, many NGOs are facing the threat of closure and job cuts.

Story continues below Advertisement

A large amount of corporate Social Responsibility (CSR), retail and philanthropic funds were expected to go to COVID-19 healthcare and relief, both in the near- and medium-term, impacting the overall funds supply available to NGOs.

That in turn is bound to hit non-COVID activities of such organisations such as literacy programmes, building community participation, women empowerment, sustainable development, advocacy and raising awareness, among other social welfare projects, where many NGOs  - apart from a few rotten apples - have been offering yeoman services, to even places where the government machinery is unable to reach in a vast and diverse country like India.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show